medisourceasia.com Industry News

Page 2 of  2


About 
MediSource Asia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

L&T eyes global equipment market

ENGINEERING and construction conglomerate, Larsen & Toubro (L&T) has decided to tap the global medical equipment market in a big way. This would be achieved mainly through offering contract manufacturing to foreign countries and a European partner has already been tied-up for this purpose. Furthermore it would shortly seek the FDA approval to enter the US equipment market. The company officials announced this at a press conference held recently in the city. The move is in line with its restructuring plan, Project Blue Chip, as recommended by Boston Consulting Group (BCG).

L&T has been the only major Indian company involved in the manufacturing of low-end equipment viz. ultrasound, monitors and surgical diathermies, indigenously since 1988. According to R N Mukhija, Sr VP Operations, in the Rs 1000 crore Indian medical equipment market, this segment is worth Rs 250-300 crore and L&T enjoys around 30 per cent share in it (Rs 60 crore). And the company envisages pocketing around 50 per cent of revenue from this business through export in the next five years.

L&T has been exporting its equipment to a few countries in the Middle East and South Asia and Africa along with France and UK. "Being Indigenously developed, it is easier for us to export our equipment," Mukhija said. He further explained that being a national player helped L&T understand the customers’ needs in a better way and work accordingly in its R&D division.

J N Vaidya, Jt general manager, "Medical Equipment Division, said that L&T’s products have been receiving overwhelming response at a number of international exhibitions viz. Medica, Hospimedica, etc. in the recent past which prompted them to consider seriously venturing into the global market. "International players have shown interest in our products and hence we would focus on manufacturing the products and allow our foreign partner to label them," he added. When asked about any plans to start manufacturing high-end equipment to compete with the existing MNCs, Vaidya said that there was no immediate plan to do son and the focus would be on three low end products where L&t is the market leader or a close second.

Speaking about the importance of aesthetics part in medical equipment, he said, "For this we have taken the help of Industrial Design Centre (IDC) at IIT Mumbai for our new products." The company has also signed and agreement with BARC for commercialising an impressive technology developed by them in cardiology, informed Vaidya.

Back | Back To Top


PLASTINDIA FOUNDATION ELECTS NEW OFFICE BEARERS

PLASTINDIA FOUNDATION elects Shyam Tibrewal as President, Mahesh K Shah as Vice-President and Arvind M Mehta as Hon. Treasurer for the period 2000-03.

Mr Shyam Tibrewal was earlier President of Gujarat State Plastic Manufacturers Association (GSPMA) and Hon. Treasurer of Plastindia Foundation. He has also been associated with many Institutions and

Organizations of national character.

Mr. Mahesh K Shah is the Chairman of Plastics Export Promotion Council (PLEXCONCIL) and Mr. Arvind M Mehta is the President of All India Plastics Manufacturers Association (AIPMA).

Plastindia Foundation is the apex body of major associations, organisations and institutions connected with plastics, with common objectives to promote the development of the plastics industry and to assist the growth of plastics and related materials and their products. The Foundation is dedicated to national progress through plastics.

 Back


USFDA approves Cadila’s Ankleshwar unit

CADILA Pharmaceuticals, the Ahmedabad based pharmaket with its Fluoxetine HCL, (anti-depressant) since the company’s bulk drug manufacturing facility at Ankleshwar has been accorded the US FDA approval for the manufacturing of the same. In fact it is for the first time that an Indian facility has got USFDA approval.

The company will now supply Fluoxetine bulk to Malinclrodt, US who will convert this drug into formulations for the market there. The company has a capacity to produce about 1,000 kg in a month at this unit. The USFDA approval to Cadila Pharma has come without any 483 comments which show the competency of the group in its facilities, documentations etc. The Ankleshwar facility encompasses one of the highest capacities in India to produce Loratidine

 Back


Advertisement

 

In the News...

Archives